Search Results (1 to 10 of 1722 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 470 Journal of Medical Internet Research
- 307 JMIR Research Protocols
- 204 JMIR Formative Research
- 130 JMIR mHealth and uHealth
- 89 JMIR Mental Health
- 88 JMIR Public Health and Surveillance
- 73 Online Journal of Public Health Informatics
- 50 JMIR Human Factors
- 45 JMIR Medical Informatics
- 30 JMIR Cancer
- 29 JMIR Medical Education
- 25 JMIR Pediatrics and Parenting
- 21 JMIR Aging
- 21 JMIR Dermatology
- 19 JMIRx Med
- 18 Interactive Journal of Medical Research
- 15 Iproceedings
- 15 JMIR Serious Games
- 13 JMIR Diabetes
- 13 JMIR Rehabilitation and Assistive Technologies
- 10 JMIR Infodemiology
- 9 JMIR Cardio
- 8 JMIR Perioperative Medicine
- 5 JMIR AI
- 4 Journal of Participatory Medicine
- 3 JMIR Nursing
- 2 JMIR Biomedical Engineering
- 2 JMIR Neurotechnology
- 1 Asian/Pacific Island Nursing Journal
- 1 JMIR Bioinformatics and Biotechnology
- 1 JMIR Data
- 1 Medicine 2.0
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR XR and Spatial Computing (JMXR)
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Capturing Community Perspectives in a Statewide Cancer Needs Assessment: Online Focus Group Study
JMIR Cancer 2025;11:e63717
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Sodium oxybate, the pharmacological agent used in this study, acts as a GABA-B receptor agonist and a precursor of GABA [24]. It was administered in doses ranging between 0.01 and 0.1 g/kg, 3 times daily either orally or intravenously (equivalent to 2.4-24 g/d for an 80 kg patient). Among patients with schizophrenia and catatonia, approximately 30 participants, the study showed a reduction of catatonic symptoms ranging from 60% to 70%.
JMIR Res Protoc 2025;14:e68356
Download Citation: END BibTex RIS